Mononuclear_JJ
leukocyte_NN
glucocorticoid_NN
receptor_NN
binding_NN
characteristics_NNS
and_CC
down-regulation_NN
in_IN
major_JJ
depression_NN
._.

Some_DT
patients_NNS
with_IN
major_JJ
depressive_JJ
disorder_NN
-LRB-_-LRB-
MDD_NN
-RRB-_-RRB-
have_VBP
elevated_JJ
plasma_NN
cortisol_NN
concentrations_NNS
and_CC
show_VBP
failure_NN
to_TO
suppress_VB
cortisol_NN
secretion_NN
upon_IN
administration_NN
of_IN
dexamethasone_NN
-LRB-_-LRB-
DEX_NN
-RRB-_-RRB-
,_,
yet_CC
they_PRP
do_VBP
not_RB
have_VB
Cushingoid_JJ
features_NNS
._.

To_TO
study_VB
whether_IN
this_DT
represents_VBZ
glucocorticoid_NN
-LRB-_-LRB-
GC_NN
-RRB-_-RRB-
resistance_NN
,_,
-LCB-_-LRB-
3H-RCB_NN
--_:
DEX-binding_JJ
assays_NNS
were_VBD
used_VBN
to_TO
measure_VB
,_,
in_FW
vitro_FW
,_,
the_DT
GC_NN
receptor_NN
affinity_NN
-LRB-_-LRB-
1\/Kd_NN
-RRB-_-RRB-
and_CC
number_NN
-LRB-_-LRB-
Bmax_NN
-RRB-_-RRB-
in_IN
mononuclear_JJ
leukocytes_NNS
of_IN
11_CD
MDD_NN
patients_NNS
and_CC
15_CD
control_JJ
subjects_NNS
._.

No_DT
receptor_NN
abnormalities_NNS
were_VBD
detected_VBN
in_IN
the_DT
MDD_NN
group_NN
;_:
thus_RB
any_DT
cellular_JJ
defect_NN
leading_VBG
to_TO
a_DT
lack_NN
of_IN
responsiveness_NN
to_TO
GC_NN
in_IN
the_DT
MDD_NN
patients_NNS
,_,
if_IN
present_JJ
,_,
probably_RB
lies_VBZ
beyond_IN
the_DT
initial_JJ
receptor_NN
binding_NN
._.

DEX_NN
-LRB-_-LRB-
1.0_CD
mg_NN
orally_NN
-RRB-_-RRB-
was_VBD
administered_VBN
to_TO
study_VB
in_FW
vivo_FW
GC_NN
receptor_NN
down-regulation_NN
._.

Compared_VBN
to_TO
the_DT
control_NN
group_NN
,_,
fewer_JJR
depressed_JJ
subjects_NNS
down-regulated_VBD
Bmax_NN
after_IN
DEX_NN
._.

By_IN
paired_JJ
t-test_NN
,_,
Bmax_NN
decreased_VBD
significantly_RB
in_IN
the_DT
control_NN
group_NN
but_CC
not_RB
in_IN
the_DT
depressed_JJ
group_NN
._.

Receptor_NN
number_NN
on_IN
the_DT
control_NN
day_NN
did_VBD
not_RB
correlate_VB
significantly_RB
with_IN
the_DT
degree_NN
of_IN
receptor_NN
down-regulation_NN
,_,
severity_NN
of_IN
depression_NN
or_CC
cortisol_NN
concentrations_NNS
across_IN
all_PDT
the_DT
subjects_NNS
._.

These_DT
results_NNS
do_VBP
not_RB
lend_VB
support_NN
to_TO
previous_JJ
reports_NNS
suggesting_VBG
that_IN
GC_NN
resistance_NN
in_IN
MDD_NN
results_VBZ
from_IN
a_DT
GC_NN
receptor-binding_JJ
abnormality_NN
,_,
and_CC
they_PRP
emphasize_VBP
the_DT
importance_NN
of_IN
considering_VBG
receptor_NN
studies_NNS
in_IN
the_DT
context_NN
of_IN
GC-mediated_JJ
cell_NN
processes_NNS
in_IN
order_NN
to_TO
identify_VB
the_DT
exact_JJ
cellular_JJ
defect_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
leading_VBG
to_TO
GC_NN
resistance_NN
._.

